Transcode Therapeutics, Inc.
RNAZ· Nasdaq
Transcode Therapeutics, Inc.
- Last sale
- Oct 6, 2026 · +1.13%
- Market cap
- $30.31M
- 16.93M shares
- Filings
- 323
Price
Oct 6, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $13,421,848 | reported | |
| FY 2024 | 2024-12-31 | $9,706,358 | reported | |
| FY 2023 | 2023-12-31 | $12,263,530 | reported | |
| FY 2022 | 2022-12-31 | $10,232,366 | reported | |
| FY 2021 | 2021-12-31 | $2,753,966 | reported | |
| FY 2020 | 2020-12-31 | $284,459 | reported |
Transcode Therapeutics, Inc. · CIK 1829635 · Engraved from SEC EDGAR
